Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Shoppers/Maple/MDX
View:
Post by Dunworkin2 on Feb 04, 2022 4:16pm

Shoppers/Maple/MDX

Wondering if Mdx has ever explored a potential deal in British Colombia with Shoppers Drug Mart and Maple Health. Seems to me that Mdx would be a good addition similar to the last press release where physicians and siascopy centres work in unison. 

Ie. Patient does a virtual visit with a Maple health doctor who does a referral to Shoppers (or elsewhere) for a Siascopy.

Mdx could cover all of BC.

https://www1.shoppersdrugmart.ca/en/health-and-pharmacy/maple-virtual-care

Comment by Insightful1 on Feb 04, 2022 5:16pm
I would be suprised if MedX wasn't having discussions with all the major teleheath companies and pharmacies because they cannot assess pigmented lesions. This would be a perfect fit. I am sure we will continue to hear more developments in Q1 as they promised.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities